The Campbell's Company offers a compelling 5%+ dividend yield, providing downside support amid margin compression and sales headwinds. CPB's dividend is well-covered by earnings, with no reduction ...
The Campbell's Company remains a Sell, with shares down 15% since my last rating and ongoing margin and leverage concerns. CPB faces structural headwinds in snacks from GLP-1 drugs, persistent margin ...
Packaged food company Campbell's (NASDAQ:CPB) reported Q3 CY2025 results topping the market’s revenue expectations , but sales fell by 3.4% year on year to $2.68 billion. Its non-GAAP profit of $0.77 ...
Campbell's (CPB) reported $2.68 billion in revenue for the quarter ended October 2025, representing a year-over-year decline of 3.4%. EPS of $0.77 for the same period compares to $0.89 a year ago. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback